سعر فاست كيور 20مجم 14 كبسولة 2024

Omeprazole 20 mg oral capsules (October Pharma, Egypt), pack of 14 capsules.

• Short-term treatment of active duodenal ulcer.Population: AdultsDailyMed (U.S. NLM)
• H. pylori eradication (with clarithromycin ± amoxicillin) to reduce the risk of duodenal ulcer recurrence.Population: AdultsDailyMed (U.S. NLM)
• Short-term treatment of active benign gastric ulcer.Population: AdultsDailyMed (U.S. NLM)

• Most common in clinical trials (≥2%): headache (7%), abdominal pain (5%), nausea (4%), diarrhea (4%), vomiting (3%) and flatulence (3%); also acid regurgitation, upper respiratory infection, constipation, dizziness and rash (2%).International label, equivalent formulation · DailyMed (U.S. NLM)
• Serious: acute tubulointerstitial nephritis, C. difficile-associated diarrhea, bone fracture, cutaneous and systemic lupus erythematosus, vitamin B12 deficiency, hypomagnesemia and fundic gland polyps; postmarketing hypersensitivity reactions including anaphylaxis.International label, equivalent formulation · DailyMed (U.S. NLM)

• Known hypersensitivity (including anaphylaxis, angioedema, bronchospasm, acute tubulointerstitial nephritis, urticaria) to the formulation or any substituted benzimidazole.International label, equivalent formulation · DailyMed (U.S. NLM)
• Patients receiving rilpivirine-containing products.International label, equivalent formulation · DailyMed (U.S. NLM)

• Symptomatic response does not exclude gastric malignancy; consider further evaluation (endoscopy in older patients) if response is suboptimal or symptoms relapse early.International label, equivalent formulation · DailyMed (U.S. NLM)
• Acute tubulointerstitial nephritis may occur at any time; discontinue if suspected.International label, equivalent formulation · DailyMed (U.S. NLM)
• Increased risk of Clostridioides difficile-associated diarrhea, osteoporosis-related fractures (high-dose/long-term use), vitamin B12 deficiency (long-term), hypomagnesemia and fundic gland polyps; use the lowest dose and shortest duration appropriate.International label, equivalent formulation · DailyMed (U.S. NLM)

• RilpivirineContraindicated: PPIs decrease rilpivirine exposure.DailyMed (U.S. NLM)
• ClopidogrelAvoid concomitant use: omeprazole (CYP2C19 inhibition) reduces formation of the active clopidogrel metabolite and its antiplatelet activity.DailyMed (U.S. NLM)
• St John's wort, rifampinAvoid: CYP2C19/CYP3A4 inducers substantially decrease omeprazole concentrations.DailyMed (U.S. NLM)

• No adequate well-controlled studies in pregnant women; epidemiologic data do not show an increased risk of major malformations or other adverse outcomes with first-trimester use; dose-dependent embryo-lethality at high doses in animals.International label, equivalent formulation · DailyMed (U.S. NLM)
• Limited data suggest omeprazole may be present in human milk; no data on effects on the breastfed infant or milk production; weigh benefits of breastfeeding against maternal need.International label, equivalent formulation · DailyMed (U.S. NLM)

• Omeprazole: Suppresses gastric acid secretion by specific inhibition of the H+/K+ ATPase (proton pump) at the secretory surface of the gastric parietal cell (US label).